SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: A systematic review and meta-analysis

Differences in the distribution of stroke subtypes in a UK black stroke population – final results from the South London Ethnicity and Stroke Study

(2016) Giosue Gulli et al.   BMC Medicine

Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis

(2016) Christian Sonesson et al.   Cardiovascular Diabetology

Stroke paradox with SGLT-2 inhibitors: a play of chance or a viscosity-mediated reality?

(2016) Konstantinos P Imprialos et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Comparing the Clinical Outcomes Between Insulin-treated and Non-insulin-treated Patients With Type 2 Diabetes Mellitus After Coronary Artery Bypass Surgery

(2016) Krishna Munnee et al.   MEDICINE

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

(2016) Steven P. Marso et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pioglitazone for Secondary Stroke Prevention

(2016) Meng Lee et al.   STROKE

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis

(2016) Jason H Y Wu et al.   Lancet Diabetes & Endocrinology

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

(2015) Brian Hutton et al.   ANNALS OF INTERNAL MEDICINE

SGLT-2 inhibitors and cardiovascular risk: Proposed pathways and review of ongoing outcome trials

(2015) Silvio E Inzucchi et al.   Diabetes & Vascular Disease Research

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people

(2015) Anoop Dinesh Shah et al.   Lancet Diabetes & Endocrinology

Sodium Intake in a Cross-Sectional, Representative Sample of New York City Adults

(2014) Sonia Y. Angell et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Prevalence of Childhood and Adult Obesity in the United States, 2011-2012

(2014) Cynthia L. Ogden et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity

(2014) Matthias Oelze et al.   PLoS One

Dietary Patterns Are Associated With Incident Stroke and Contribute to Excess Risk of Stroke in Black Americans

(2013) Suzanne E. Judd et al.   STROKE

SGLT2 inhibition — a novel strategy for diabetes treatment

(2010) Edward C. Chao et al.   NATURE REVIEWS DRUG DISCOVERY